Advertisement

Acute Lymphoblastic Leukemia

Cytochemistry and Ultrastructure with Emphasis on the Hand Mirror Variant
  • Harold R. Schumacher
  • James D. Cotelingam
  • William K. Hummer
Part of the Developments in Oncology Series book series (DION, volume 14)

Abstract

The classification of the lymphoblastic leukemias has undergone change in recent years. The two most widely accepted classifications are the United Nations’ World Health Organization (WHO) classification [1] and the French-American-British (FAB) classification based on Wright-Giemsa stained preparations of bone marrow smears [2, 3]. The FAB classification will be used throughout this chapter. This classification divides the lymphoblastic leukemias into L1, L2, and L3 groups. The relationship between the WHO classification and the FAB classification are shown in figure 11–1. The L2 group is most commonly observed in children and is characterized by predominately small cells with inconspicuous nucleoli and a scant amount of cytoplasm. The L2 group, most commonly seen in adults, demonstrates large heterogeneous cells, with one or more prominent nucleoli and variable, often moderately abundant, cytoplasm.

Keywords

Acute Lymphoblastic Leukemia Acid Phosphatase Acute Myeloid Leukemia Patient Blast Crisis Original Magnification 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mathé G, Seligmann M, Tubiana M. Recenc results in cancer research, lymphoid neoplasia: I. Classification, categorization, and natural history. Berlin: Springer Verlag. 1978, pp. 5–18.Google Scholar
  2. 2.
    Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. Br J Haematol 33: 451–458, 1976.PubMedCrossRefGoogle Scholar
  3. 3.
    Gralnick HR, Galton DAG, Catovsky D. et al. Classification of acute leukaemia. Ann Int Med 87: 740–753, 1977.Google Scholar
  4. 4.
    Norberg B, Rydgren L, Stcnstam M. Amoeboid movement configuration: A cell configuration observed in tumor cells from three cases of bone marrow neoplasia. ScandJ Haematol 13: 294–304, 1974.CrossRefGoogle Scholar
  5. 5.
    Sjögren U. Amoeboid movemenr configuration and mitotic indices of lymphoid cells from children with acute lymphoblastic leukemia. Lymphol 9: 69–71, 1976.Google Scholar
  6. 6.
    Stass SA, Perlin H, Jaffe ES, et al. Acute lymphoblastic leukemia-hand mirror cell variant: A detailed cytological and ultra- structural study with analysis of immunological surface markers. Am J Hematol 4: 67–77, 1978.PubMedCrossRefGoogle Scholar
  7. 7.
    Schumacher HR, Champion JE, Thomas WJ, et al. Acute lymphoblastic leukemia- hand mirror variant. An analysis of a large-group of patients. Am J Hematol 7: 11–17, 1979.PubMedCrossRefGoogle Scholar
  8. 8.
    Stern R, Widirstky ST, Wurster-Hill DH, et al. Hand mirror cell leukemia associated with mental retardation: Immunologic, chromosome, and morphological studies. Blood 54: 703–712, 1979.PubMedGoogle Scholar
  9. 9.
    Schumacher HR, Perlin E, Stass SA, et al. Hand mirror cell leukemia. Lancet: 655– 656, 1977.Google Scholar
  10. 10.
    McFarland W, Heilman DH. Lymphocyte foot appendage: Its role in lymphocyte function and its immunological reactions. Nature 205: 887–888, 1965.PubMedCrossRefGoogle Scholar
  11. 11.
    McFarland W, Schecter GP. The lymphocyte in immunological reactions in vitro: Ultrastructural studies. Blood 35: 683–688, 1970.PubMedGoogle Scholar
  12. 12.
    Schreiner GF, Unanue ER. The modulation of spontaneous and anti-Ig-stimulated motility of lymphocytes by cyclic nucleotides and adrenergic and cholinergic agents. J Immunol 114: 802–808, 1975.PubMedGoogle Scholar
  13. 13.
    Borella L, Sen L. T cell surface markers on lymphoblasts from acute lymphocytic leukemia. J Immunol 111: 1257–1260, 1973.PubMedGoogle Scholar
  14. 14.
    Flandrin G, Brouet JC, Daniel MT, et al. Acute leukemia with Burkitt’s tumor cells: A study of six cases with special reference to lymphocyte surface markers. Blood 45: 183–188, 1975.PubMedGoogle Scholar
  15. 15.
    Brouet JC, Seligmann M. The immunological classification of acute lymphoblastic leukemias. Cancer 42: 817–827, 1978.PubMedCrossRefGoogle Scholar
  16. 16.
    Greaves MF, Janossy G. Patterns of gene expression and the cellular origins of human leukemias. Biochem Biophys Acta 516: 193–230, 1978.PubMedGoogle Scholar
  17. 17.
    Janossy G, Hoffbrand AV, Greaves MF, et al. Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukaemia: A multiparameter analysis of 300 cases. Br J Haematol 44: 221–234, 1979.CrossRefGoogle Scholar
  18. 18.
    Roberts M, Greaves M, Janossy G, et al. Acute lymphoblastic leukemia (ALL) associated antigen: I. Expression in different hematopoetic malignancies. Leuk Res 2: 105–114, 1978.CrossRefGoogle Scholar
  19. 19.
    Greaves MF. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res 41: 4752–4766, 1981.PubMedGoogle Scholar
  20. 20.
    Bennett JM, Catovsky D, Daniel MT, et al. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 47: 553–561, 1981.PubMedCrossRefGoogle Scholar
  21. 21.
    Keleti J, Revesz T. Schuler D. Morpho¬logical diagnosis in childhood leukaemia. Br J Haematol 40: 501–502, 1978.PubMedCrossRefGoogle Scholar
  22. 22.
    Coccia PF, Miller DR. Kessey JH, et al. Relationship of blast cell surface markers and morphology (FAB classification) in childhood acute lymphocytic leukemia (ALL). Blood 54(suppl l):182a, 1979, abstract.Google Scholar
  23. 23.
    Hann IM, Evans DI, Palmer MK et al. The prognostic significance of morphological features in childhood acute lymphoblastic leukaemia. Clin Lab Haematol 1: 215–226. 1979.PubMedCrossRefGoogle Scholar
  24. 24.
    Viana MB, Maurer HS, Ferenc C. Subclassification of acute lymphoblastic leukaemia in children: Analysis of the reproducibility of morphological criteria and prognostic implications. Br J Haematol 44: 383–588, 1980.PubMedCrossRefGoogle Scholar
  25. 25.
    Lewis WH. Locomotion of lymphocytes. Bull Johns Hopkins Hosp 49: 29–36, 1931.Google Scholar
  26. 26.
    Rich AR, Wintrobe MM, Lewis MR. Differentiation of myeloblasts from lympho-blasts by their manner of locomotion, motion picture study of cells of normal bone marrow and lymph nodes, and of leukemic blood. Bull Johns Hopkins Hosp 65: 291–309, 1939.Google Scholar
  27. 27.
    De Bruyn PPH. Locomotion of blood cells in tissue cultures. Anat Rec 89: 43–63, 1944.CrossRefGoogle Scholar
  28. 28.
    Sjogren U, Norberg B. Rydgren L. Amoeboid movement configuration in tumour cells of bone marrow smears from patients with leukaemia. Acta Med Scand 201: 381–386. 1977.PubMedCrossRefGoogle Scholar
  29. 29.
    Glassy HF, Sun NCJ, Okun DB. Hand mirror cell leukemia: Report of nine cases and a review of the literature. Am J Clin Pathol 74: 651–656, 1980.PubMedGoogle Scholar
  30. 30.
    Shah-Reddy I, Mirchandani I, Bishop CR. Hand mirror cell leukemia—immunologic and ultrastructural studies. Cancer 47: 715–719. 1981.PubMedCrossRefGoogle Scholar
  31. 31.
    Schumacher HR, Rainey T, Davidson L, et al. American Burkitt’s lymphoma-hand mirror variant: A detailed investigation of cytologic, ultrastructural, and immunologic features. Am J Clin Pathol 70: 937–944, 1978.PubMedGoogle Scholar
  32. 32.
    Stass SA, Phillips TM. Weislow OS, et al. Antigen-antibody complexes related to the baboon endogenous virus in humans with acute lymphoblastic leukemia-hand mirror variant (ALL-HMC). Blood 56:661–666, 1980.PubMedGoogle Scholar
  33. 33.
    Schumacher HR. Clapp WL, Thomas WJ, et al. Acute lymphoblastic leukemia: hand mirror variant. Arch Pathol Lab Med 104: 134–136, 1980.PubMedGoogle Scholar
  34. 34.
    Spiers ASD. The clinical features of chronic granulocytic leukaemia. Clin Haematol 6: 77–95. 1977.PubMedGoogle Scholar
  35. 35.
    Spiers ASD. Metamorphosis of chronic granulocytic leukaemia: Diagnosis, classification, and management. Br J Haematol 41:1–7, 19?9.Google Scholar
  36. 36.
    Spiers AS, Bain BJ. Turner JE. The peripheral blood in chronic granulocytic leukaemia: Study of 50 untreated Philadelphia-positive cases. Scand J Haematol 18:25–38, 1977.PubMedCrossRefGoogle Scholar
  37. 37.
    Greaves MF. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res 41: 4752–4766, 1981.PubMedGoogle Scholar
  38. 38.
    Janossy G. Roberts M, Greaves MF. Target cell in chronic myeloid leukaemia and its relationship to acutc lymphoid leukaemia. Lancet 2: 1058–1061, 1976.PubMedCrossRefGoogle Scholar
  39. 39.
    Greaves MF. Verbi W, Reeves BR, et al. “Pre B” phenotypes in blast crisis of Ph1 positive CML: Evidence for a pluripotential stem cell:“target”. Leuk Res 3:181–191. 1979.PubMedCrossRefGoogle Scholar
  40. 40.
    Janossy G. Woodruff RK. Paxton A. et al. Membrane marker and cell separation studies in Ph1 positive leukemia. Blood 51: 861–877, 1978.PubMedGoogle Scholar
  41. 41.
    Boggs DR. Hematopoietic stem cell theory in relation to possible lymphoblastic conversion of chronic myeloid leukemia. Blood 44: 449–453. 1974.PubMedGoogle Scholar
  42. 42.
    Fialkow PJ, Denman AM, Singer J, et al. Human myeloproliferative disorders: Clonal origin in pluripotential stem cells. In: Clarkson B, Marks PA, Till JE, eds. Differentiation of normal and neoplastic hemopoietic cells. Cold Spring Harbor, N.Y.: Cold Spring Harbor Publishers, 1978. pp. 131–144.Google Scholar
  43. 43.
    Rosenthal S, Canellos GP, DeVita VT, et al. Characteristics of blast cells in chronic granulocyte leukemia. Blood 49: 705–714, 1977.PubMedGoogle Scholar
  44. 44.
    Rosenthal S, Canellos GP, Whang-Peng, et al Blast crisis of chronic granulocytic leukemia: Morphologic variants and therapeutic implications. Am J Med 63: 542–54, 1977.PubMedCrossRefGoogle Scholar
  45. 45.
    Nieman, RS. Erythroblastic transformation in myeloproliferative disorders. Cancer 46: 1636–1640, 1980.CrossRefGoogle Scholar
  46. 46.
    Breton-Gorius J, Reyes F, Vernant JP, et al. The blast crisis of chronic granulocytic leukemia: Megakaryoblastic nature of cells as revealed by the presence of platelet- peroxidase. A cytochemical ultrastructural study. Br J Haematol 39: 295–303, 1978.PubMedCrossRefGoogle Scholar
  47. 47.
    Kass I.. Chronic granulocytic leukemia. In: Leukemia cytology cytochemistry. Philadelphia: J.B. Lippincott, 1982, p. 147.Google Scholar
  48. 48.
    Sasaki R, Takaku S, Sakamoto, et al. Terminal deoxynucleoridyl transferase activity and B tell markers in chronic myelogenous leukemia blast crisis. Acta Hematol 62: 143–147, 1979.CrossRefGoogle Scholar
  49. 49.
    Fialkow PJ, Denman AM, Jacobson, RJ, et al. Chronic myelocytic leukemia: Origin of some lymphocytes from leukemic stem cells. J Clin Invest 62: 815–823, 1978.PubMedCrossRefGoogle Scholar
  50. 50.
    Marks SM, Baltimore D, McCaffrey R Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia. New Eng J Med 298: 812–814, 1978.PubMedCrossRefGoogle Scholar
  51. 51.
    Shumak KH. Baker MA, Taub RN, et al. Myeloblasts and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis. Cancer Res 40: 4048–4052, 1980.PubMedGoogle Scholar
  52. 52.
    Oken MM, Sarin PS. Gallo RC. et al. Terminal transferase levels in chronic myelogenous leukemia in blast crisis and in remission. Leuk Res 2:173–180, 1978.CrossRefGoogle Scholar
  53. 53.
    Sawada H, Tashima M, Konishi H. et al. Characteristics of the blast crisis with terminal deoxynucleotidyl transferase positive- blasts in chronic granulocytic leukemia. Acta Hematol Jpn 44: 872–880. 1981.Google Scholar
  54. 54.
    Janossy G. Woodruff, RK, Pippard MJ, et al. Relation of lymphoid phenotype and response to chemotherapy incorporating vincristine-prednisolone in the acute phase of Ph1 positive leukemia. Cancer 43: 426–434, 1979.PubMedCrossRefGoogle Scholar
  55. 55.
    Nathwani BN. Kim H, Rappaport H. Malignant lymphoma, lymphoblastic. Cancer 38:964–983. 1976.PubMedCrossRefGoogle Scholar
  56. 56.
    Barcos MP. Lukes RJ. Malignant lymphoma of convoluted lymphocytes A new entity of possible T cell type. In Sinks LF. Godden JD, eds. Conflict in childhood cancer: An evaluation of current management. Proceedings of the symposium, Rosewell Institute, (Buffalo) N.Y., (Sept) I974. Progress in Clinical Biological Research, vol 4. New York: Alan R Liss, 1975, pp. 147–178.Google Scholar
  57. 57.
    Boucheix C, Diebold J. Bernadou A. et al. Lymphoblastic lymphoma leukemia with convoluted nuclei: The question of its relation to the T-cell lineage studied in 13 patients. Cancer 45: 1569–1577, 1980.PubMedCrossRefGoogle Scholar
  58. 58.
    Dorfman RF. Classification of non-Hodgkin’s lymphomas. Lancet 2: 961–962, 1974.PubMedCrossRefGoogle Scholar
  59. 59.
    Lukes RJ, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer 34: 1488–1503, 1974.PubMedCrossRefGoogle Scholar
  60. 60.
    Jaffe ES, Braylan RC, Nanba K, et al: Functional markers: A new perspective on malignant lymphomas. Cancer Treat Rep 61: 953–962, 1977.PubMedGoogle Scholar
  61. 61.
    Kaplan J, Mastrangelo R, Peterson WD Jr. Childhood lymphoblastic lymphoma, a cancer of thymus-derived lymphocytes. Cancer Res 34: 521–525. 1974.PubMedGoogle Scholar
  62. 62.
    Jaffe ES, Braylan RC, Frank MM. et al. Heterogeneity of immunologic markers and surface morphology in childhood lymphoblastic lymphoma. Blood 48: 213–222, 1976.PubMedGoogle Scholar
  63. 63.
    Stein H, Petersen N, Gaedicke G, et al. Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells. Int J Cancer 17: 292–295. 1976.PubMedCrossRefGoogle Scholar
  64. 64.
    Lukes RJ, Taylor CR, Parker JW et al. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol 90: 461–485, 1978.PubMedGoogle Scholar
  65. 65.
    Palutke M, Tranchida L. T cell lymphoma: Report of a case. Am J Clin Pathol 64: 26–33, 1975.PubMedGoogle Scholar
  66. 66.
    Palutke M, Patt DJ. Weise R. et al. T cell leukemia lymphoma in young adults Am J Clin Pathol 68:429–439, 1977.PubMedGoogle Scholar
  67. 67.
    Kersey JH, Gajl-Peczalska KJ, Coccia PF, et al. The nature of childhood leukemia and lymphoma. Am J Pathol 90: 487–496. 1978.PubMedGoogle Scholar
  68. 68.
    Berard CW. Jaffe ES. Braylan RC. et al. Immunologic aspects and pathology of the malignant lymphomas. Cancer 42: 911–921. 1978.PubMedCrossRefGoogle Scholar
  69. 69.
    Coccia PF, Kersey JH, Kazamiera J et al. Prognostic significance of surface marker analysis in childhood non-Hodgkin’s lym-phoproliferative malignancies. Am I Hematol 1: 405–417, 1976.CrossRefGoogle Scholar
  70. 70.
    Dauber LG, Rubinstein A. Null-cell leukemia in course of T-cell lymphoma. NY State J Med 81: 237–241, 1981.Google Scholar
  71. 71.
    Gatien JG, Schnecbcrger F.F., Merler F.. Analysis of human thymocyte subpopulations using discontinuous gradients of albumin: Precursor lymphocytes in human thymus. Eur J Immunol 5: 312–317, 1975.PubMedCrossRefGoogle Scholar
  72. 72.
    Stein H, Muller-Hermelink HK. Simultaneous presence of receptors for complement and sheep red blood cells on human fetal thymocytes. Br J Haematol 36: 225–230, 1977.PubMedCrossRefGoogle Scholar
  73. 73.
    Hayhoe FGJ, Quaglino 1). Haematological cytochemistry. Edinburgh/London/ New York: Churchill Livingstone, p. 265, 1980.Google Scholar
  74. 74.
    Laurie HC. Duration of remissions in lymphoblastic leukaemia of childhood. Br Med J 2: 95–97, 1968.PubMedCrossRefGoogle Scholar
  75. 75.
    Vowels MR. Willoughby MLN. Cyclic chemotherapy in acute lymphoblastic leukemia of childhood: 5 year survivals. Arch Diss Child 48: 436–440, 1973.PubMedCrossRefGoogle Scholar
  76. 76.
    Fledges AJ, Aur RJA, Verzosa MS, et al. Periodic acid-Schiff reaction, a useful index of duration of complete remission in acute childhood lymphocytic leukaemia. Acta Haematol 52: 8–13, 1974.CrossRefGoogle Scholar
  77. 77.
    Ascari E, Marini G, Invernizzi R, et al. On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukaemia. Haematologica 60: 300–307, 1975.PubMedGoogle Scholar
  78. 78.
    Paolucci G, Rosito P. Mancini A, et al. Relazione tra percentuale di blasti PAS positivi alla diagnosi e durata della prima remissione nella leucemia acuta linfolbastica del bambino. Haematologica 62: 250–257, 1977.PubMedGoogle Scholar
  79. 79.
    Bennett JM, Henderson ES. Lymphoblastic leukemia. Br Med J 2: 513, 1969.PubMedCrossRefGoogle Scholar
  80. 80.
    Berrebi A, Malasakova V. Oberling F. et al. Application des techniques cytochimiques 3 47 cas de leucémies aigues: Modifications cytochimiques au cours de I’ evolution. Semin Hop Paris 49: 633–643. 1973.Google Scholar
  81. 81.
    Humphrey GB, Nesbit ME. Brunning RD. Prognostic value of the periodic acid-Schiff (PAS) reaction in acute lymphoblastic leukemia. Am J Clin Pathol 61:393–397. 1974.PubMedGoogle Scholar
  82. 82.
    Shaw MT. Humphrey GB, Lawrence R, et al. Lack of prognostic vaue of the periodic acid-Schiff reaction and blast cell size in childhood acute Iymphocyctic leukemia. Am J Hematol 2: 237–243, 1977.PubMedCrossRefGoogle Scholar
  83. 83.
    Lilleyman JS, Mills, V, Sugden PJ, et al. Periodic acid-Schiff reaction and prognosis in lymphoblastic leukemia. J Clin Pathol 32: 158–161, 1979.PubMedCrossRefGoogle Scholar
  84. 84.
    McKenna RW, Brynes RK, Nesbit ME, et al. Cytochemical profiles in acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 1: 263–275, 1979.PubMedCrossRefGoogle Scholar
  85. 85.
    Catovsky D, Costello C. Cytochemistry of normal and leukemic lymphocytes: A review. Basic Appl Histochem 23 (4): 255–270, 1979.PubMedGoogle Scholar
  86. 86.
    Grossi CE, Webb SR, Zicca A. et al. Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG. J Exp Med 147: 1405–1417, 1978.PubMedCrossRefGoogle Scholar
  87. 87.
    Hayhoe FGJ, Quaglino D. Haematological cytochemistry. Edinburgh/London/ New York: Churchill Livingstone, 1980, p 149.Google Scholar
  88. 88.
    Meier J. Coleman MS, Hutron JJ. Adenosine deaminase activity in peripheral blood cells of patients with haemotological malignancies. Br I Cancer 33: 312–319, 1976.CrossRefGoogle Scholar
  89. 89.
    Tung R, Silber R. Quagliata F. et al. Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations. J Clin Invest 57: 756–761, 1976.PubMedCrossRefGoogle Scholar
  90. 90.
    Zimmer J, Khalifa AS, Lightbody JJ. Decreased lymphocyte adenosine deaminase activity in acute lymphocytic leukemic children and their parents. Cancer Res 35: 68–70, 1975.PubMedGoogle Scholar
  91. 91.
    Coleman MS. Greenwood MF, Hutton JJ, et al. Adenosine deaminase, terminal deoxynucleotidyl transferase (TdT), and cell surface markers in childhood acute leukemia Blood 52: 1 125–1131, 1978.Google Scholar
  92. 92.
    Koya M, Kanoh T, Sawada H. et al. Adenosine deaminase and ecto-5’ nucleotidase activities in various leukemias with special reference to blast crisis: Significance of ecto-5’ nucleotidase in lymphoid blast crisis of chronic myeloid leukemia. Blood 58: 1107–1111, 1981.PubMedGoogle Scholar
  93. 93.
    Ellis RB. Rapson NT. Patrick AD, et al. Expression of hexosaminidase isoenzymes in childhood leukemia. New Engl J Med 298: 476–480, 1978.PubMedCrossRefGoogle Scholar
  94. 94.
    Ellis RB, Ikonne JU, Masson PK. DEAE-cellulose microcolumn chromatography coupled with automated assay: Application to the resolution of N-acetyl-β-D-hexosaminidase components. Anal Biochem 63: 5–11, 1975.PubMedCrossRefGoogle Scholar
  95. 95.
    Ellis RB. Patrick AD. Component forms of acid hydrolases in subcellular granules from human lcukocytes. Adv Exp Med Biol 68: 49–62, 1976.PubMedGoogle Scholar
  96. 96.
    Greaves MF. Habeshaw JA. Stansfield AG Lymphoproliferative disorders. In: Atlas of blood cells: Zucker-Franklin D, Greaves MF, et al., eds. Function and pathology, vol 2. Philadelphia: Lea & Febiger, 1981. pp 409–524.Google Scholar
  97. 97.
    Chang LM. Development of terminal deoxynucleotidyl transferase activity in embryonic calf thymus. Biochem Biophys Res Comm 44: 124–131. 1971.PubMedCrossRefGoogle Scholar
  98. 98.
    Coleman MS. Hutton JJ, De Simone P. et al. Terminal deoxyribonucleotidyl transferase in human leukemia. Proc Natl Acad Sci USA 71: 4404–4408. 1974.PubMedCrossRefGoogle Scholar
  99. 99.
    Bollum FJ. Preparation of oligodeoxynucleoudes. In: Cantoni GL, Davies DR, eds. Procedures in nucleic acid research, vol I. New York: Harper & Row. 1966, pp 592–599.Google Scholar
  100. 100.
    Stass SA, Schumacher HR, Keneklis TP. et al. Terminal deoxynucleotidyl transferase immunofluorescence of bone marrow smears: Experience in 156 cases. Am J Clin Pathol 72. 898–903, 1979.PubMedGoogle Scholar
  101. 101.
    Coleman MS, Hutton JJ. Terminal transferase. In: Catovsky D, ed. The leukaemic cell. Edinburgh/London/New York. Churchill Livingstone. 1981, pp 203 - 219.Google Scholar
  102. 102.
    Bollum FJ. Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 54:1203–1215, 1979-Google Scholar
  103. 103.
    Donlon JA. Jaffe ES. Braylan RC. Ter¬minal deoxynucleotidyl transferase activ¬ity in malignant Ivmphomas. New Engl J Med 297: 461–464, 1977.PubMedCrossRefGoogle Scholar
  104. 104.
    Srivastava BIS. Khan SA, Henderson F.S. High terminal deoxynucleotidyl transferase activity in acute myelogenous leukemia. Cancer Res 36: 3847–3850, 1976.Google Scholar
  105. 105.
    McGraw TP, Folds JD. Bollum FJ. et al. Terminal deoxynucleotidyl transferase positive acute myeloblasts leukemia. Am I Hemacol 10:251–258, 1981.Google Scholar
  106. 106.
    Kung PC. Long JC. McCaffrey RP, et al. Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma. Am J Med 64: 788–794, 1978.PubMedCrossRefGoogle Scholar
  107. 107.
    Hutton JJ. Coleman MS. Keneklis TP, et al. Terminal deoxynucleotidyl transferase as a tumor cell marker in leukemia and lymphoma: Results from 1,000 patients. In: Fox M, ed. Advances in medical oncology research and education. Vol. 4: Biological basis for cancer diagnosis. Oxford: Pergamon Press, 1979, pp 165–175.Google Scholar
  108. 108.
    Greenwood MF, Coleman MS, Hutton JJ. et al. Terminal deoxynucleotidyl transferase distribution in neoplastic and hematopoietic cells. J Clin Inves 59: 889–899, 1977.CrossRefGoogle Scholar
  109. 109.
    Vogler LB. Crist WM, Bockman DE, et al. Pre B cell leukemia: A new phenotype of childhood lymphoblastic leukemia. New Engl J Med 298:872–878, 19?8.Google Scholar
  110. 110.
    Greaves MF. Verbi W, Ellis R. et al. Phenotypic characteristics of pre-B ALL. Leuk Res, in press.Google Scholar
  111. 111.
    Korsmeyer SJ, Hiter PA, Raveth JV, et al. Patterns of immunoglobulin gene rearrangement. In: Knapp E, ed. Human lymphocytic leukemia. New York: Academic Press. 1981. pp 85–97.Google Scholar
  112. 112.
    Sallan SE, Ritz J, Pesando J, et al. Cell surface antigens: Prognostic implications in childhood acute lymphoblastic leukaemia. Blood 55: 395–402. 1980.PubMedGoogle Scholar
  113. 113.
    Lister TA, Roberts MM, Brearley RI., et al. Prognostic significance of cell surface phenotype in adult acute lymphoblastic leukemia. Cancer Immunol Immunother 6: 27 7–230, 1979.Google Scholar
  114. 114.
    Gutensohn W, Thiel E. High levels of 5’ nucleotidase activity in blastic chronic myelogenous leukemia with common ALL-antigen. Leuk Res 5: 505–510, 1981.PubMedCrossRefGoogle Scholar
  115. 115.
    Sasaki R. Takahu F. Aoki T. et al Terminal deoxynucleotidyl transferase activities and glucocorticoid receptors in leukemia. Br J Cancer 44: 63–67, 1981.PubMedCrossRefGoogle Scholar
  116. 116.
    Liso V, Tursi A, Bonomo L. Acute lymphoblastic leukemia hand mirror cells: Cytochemical and immunological study. Sixth meeting of the International Society of Haematology. European and African division. Aug 30—Sept 4, 1981. Athens: Hellenic Society of Hematology, 1981, p 409.Google Scholar
  117. 117.
    Catovsky D, O’Brien M, Cherchi IM. Cytochemistry: An aid to the diagnosis and classification of the acute leukemias. Rec Results Cancer Res 64: 108–112, 1978.Google Scholar
  118. 118.
    Catovsky D, Galetto J, Okos A, et al. Cytochemical profile of B and T leukemic lymphocytes with special reference to acute lymphoblastic leukemia. J Clin Pathol 27: 767–771, 1974.PubMedCrossRefGoogle Scholar
  119. 119.
    Catovsky D, Cherchi M, Greaves MF, et al. Acid phosphatase reaction in acute lymphoblastic leukaemia. Lancet 1: 749–751, 1978.PubMedCrossRefGoogle Scholar
  120. 120.
    Basso G, Cocito MG, Semenzaco G, et al. Cytochemical studies of thymocytes and T lymphocytes. Br J Haematol 44: 577–582, 1980.PubMedCrossRefGoogle Scholar
  121. 121.
    Callahan TR. Reman GH. Poplak DG. Correlation between cytochemistry and cell surface markers in acute lymphoblastic leukaemia. Blood 52: 283. 1978.Google Scholar
  122. 122.
    Dutcher TF. Cytochemistry of acute leukemias and hairy cell leukemia. Monograph Professional Educational Series. Chicago: American Society of Clinical Pathologists, 1979.Google Scholar
  123. 123.
    Kalwinsky D, Dahl G, Bowman P, et al. Utility of acid phosphatase (AP) cytochemistry in identifying T-cell acute lymphocytic leukaemia (ALL). Blood 54 190a. 1979.Google Scholar
  124. 124.
    McKenna RW, Brynes RK. Nesbit ME. et al. Cytochemical profiles in acute lymphoblastic leukemia. Am J Ped Hematol Oncol 1:263–275. 1979.CrossRefGoogle Scholar
  125. 125.
    Savage RA, Valenzuela R, Hoffman GC. Acid phosphatase staining pattern as an indicator of T-cell acute leukemia. Am J Clin Pathol 76: 760–761. 1981.PubMedGoogle Scholar
  126. 126.
    Personal observation.Google Scholar
  127. 127.
    Schumacher HR, Stass SA, Pasquale SM, et al. Hand-mirror cells Benign or malignant? Lancet 1: 1092–1093, 1978.PubMedCrossRefGoogle Scholar
  128. 128.
    Cawley JC, Haylioe FGJ. Ultrastructure of haemic cells. London: WB Saunders, 1973, pp 143–155.Google Scholar
  129. 129.
    Zucker-Franklin D. The ultrastructure of lymphocytes. Semin Hematol 6: 4–27, 1969.PubMedGoogle Scholar
  130. 130.
    Schumacher HR, Szekely IE. Park SA. et al. Acute leukemic cells: Qualitative and quantitative electron microscopy. Am J Pathol 73:27–46. 1973.PubMedGoogle Scholar
  131. 131.
    Collins RD, Smith JL. Clein GP. et al. Absence of B and T cell markers on acute lymphoblastic leukaemic cells and persistence of the T cell marker on mitogen- transformed T lymphocytes. Br J Haematol 26:615–625. 1974.PubMedCrossRefGoogle Scholar
  132. 132.
    Glick AD. Vestal BK. Flexner JM, et al. Ultrastructural study of acute lymphocytic leukaemia: Comparison with immunologic studies. Blood 52: 311–322. 1978.PubMedGoogle Scholar
  133. 133.
    Komiyama A, Saitoh H, Kuroda I. et al. Electron microscopy of T, B and null cell acurc lymphoblastic leukaemias in children. Acta Haematol Jpn 43: 47–54. 1980.Google Scholar
  134. 134.
    McKenna RW. Parkin J. Brunning RD. Morphologic and ultrastructural characteristics of T-cell acute lymphoblastic leukemia. Cancer 44: 1290–1297, 1979.PubMedCrossRefGoogle Scholar
  135. 135.
    Glick AD. Leech JH. Flexner JM. et al. Ultrastructural study of Reed-Sternberg cells: Comparison with transformed lymphocytes and histiocytes. Am J Pathol 85: 195–208, 1976.PubMedGoogle Scholar
  136. 136.
    Said JW, Pmkus GS. Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias. Cancer 48: 2630–2642, 1981.PubMedCrossRefGoogle Scholar
  137. 137.
    Zucker-Franklin D Cellular structure and neoplastic in normal and function lymphoid cells. Arch Int Med 135: 55–60, 1975.CrossRefGoogle Scholar
  138. 138.
    Schumacher HR, Szekely IE, Park SA. et al. Ultrastructural studies on the acute leukemic lymphoblast. Blut 27: 396–406, 1973.CrossRefGoogle Scholar
  139. 139.
    Schumacher HR, Szekely IE, Fisher DR. Leukemic mitochrondria: III. Acutc lymphoblastic leukemia AM J Pathol 73: 49–58, 1975.Google Scholar
  140. 140.
    Edelson RL, Kirkpatrick CH, Shevach EM. et al Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes: Morphologic and functional studies. Ann Int Med 80: 685–692, 1974.PubMedGoogle Scholar
  141. 141.
    Greenberg BR, Peter CR. Glassy F. et al. A case of T-cell lymphoma with convoluted lymphocytes. Cancer 38:1602–1607, 1976.PubMedCrossRefGoogle Scholar
  142. 142.
    Uchivama T. Yodoi J. Sagawa K.. et al. Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50: 481–492, 1977.Google Scholar
  143. 143.
    Schrek R Ultrastructure of blood lymphocytes from chronic lymphocytic and lymphosarcoma cell leukemia. J Natl Cancer Inst 48: 51–64. 1972.Google Scholar
  144. 144.
    Preud’homme JL. Seligmann M. Surface bound immunoglobulins as a cell marker in human lymphoproliferarive diseases. Blood 40: 777–794. 1972.PubMedGoogle Scholar
  145. 145.
    Sherr CJ. Uhr JW. Immunoglobulin synthesis and secretion: VI. Synthesis and intracellular transport of immunoglobulin in nonsecretory lymphoma cells. J Exp Med 133: 901–920. 1971.CrossRefGoogle Scholar
  146. 146.
    Murphy MJ. Hay JB. Morris B. et al. Ultrastructural analysis of antibody synthesis in cells from lymph and lymph nodes. Am J Pathol 66: 25–42, 1972.PubMedGoogle Scholar
  147. 147.
    Komiyama A, Tsukada M, Hanamura K, et al. Scanning and transmission electron microscopy of sheet erythrocyte-rosetting lymphoblasts in a child with acute lymphoblastic leukemia. Acta Haematol Jap 39: 306–313, 1976.Google Scholar
  148. 148.
    Watanabe Y, Tamaoki N, Habu S, et al. Fine structural study on human T and B lymphocytes. Acta Haematol Jpn 37: 655–666, 1974.Google Scholar
  149. 149.
    Catovsky D, Frisch B, Van Noorden S. T and “null” cell leukemias: Electron cytochemistry and surface morphology. Blood Cells 1: 115–124, 1975Google Scholar
  150. 150.
    Reyes F, Lejone JL, Gourdin MF, et al. The surface morphology of human B lymphocytes as revealed by immunoelec- tron microscopy. J Exp Med 141: 392–410, 1975.PubMedCrossRefGoogle Scholar
  151. 151.
    Lin PS. Cooper AG. Wortis HH. Scanning electron microscopy of human T-cell and B-Cell rosettes. New Engl J Med 289: 548–551, 1973.PubMedCrossRefGoogle Scholar
  152. 152.
    Polliack A. Siegal FP. Clarkson BD, et al. A scanning electron microscopy and immunological study of 84 cases of lymphocytic leukaemia and related lympho- proliferative disorders. Stand J Haematol 15: 359–376, 1975.CrossRefGoogle Scholar
  153. 153.
    Tsukada M, Hanamura K, Eguchi M, et al. Scanning electron microscopic study of peripheral blood lymphocytes, thymic cells, and acute lymphoblastic leukaemic cells in children. Acta Haematol Jpn 39: 43–52. 1976.Google Scholar
  154. 154.
    Sharp JW, Stass SA. Creegan WJ, et al. Acute lymphoblastic leukemia-hand mirror variant: A detailed ultrastructural study. Am J Clin Pathol 72:551–558, 1979.PubMedGoogle Scholar
  155. 155.
    Schumacher HR, Robinson JJ, Creegan WJ. et al. Electron microscopy in hand mirror cell leukaemia. Lancet 1: 1214–1215, 1977.PubMedCrossRefGoogle Scholar
  156. 156.
    Thomas WJ. Yasaka K, Strong DM. et al. Hand-mirror lymphocytes in infectious mononucleosis. Blood 55:925–930, 1980.PubMedGoogle Scholar
  157. 157.
    Thomas WJ, Duval-Arnould B. Creegan WJ, et al. Morphologic observations of contact lysis of EBV-infected B lymphocytes by autologous hand mirror T cells. Am J Hematol 12: 109–119, 1982.PubMedCrossRefGoogle Scholar
  158. 158.
    Schumacher HR, Thomas WJ, Creegan WJ, et al. Infectious mononucleosis and acute lymphoblastic leukemia—hand mirror cells: A qualitative and quantitative ultrastructural study. Am J Hematol 9: 67–77, 1980.PubMedCrossRefGoogle Scholar
  159. 159.
    Norberg B, Brandr I.. Von Mecklenburg C, et al. Hand mirror blast cells in acute leukaemia. Lancet 1: 957, 1977.PubMedCrossRefGoogle Scholar
  160. 160.
    McFarland W: Microspikes on the lymphocyte uropod. Science 163: 818–820, 1969.PubMedCrossRefGoogle Scholar
  161. 161.
    Roysion I, Sullivan JL, Penman PO, et al. Cell-mediated immunity to Epstem-Barr virus transformed lymphoblastoid cells in acute infectious mononucleosis. New Engl J Med 293: 1159–1163. 1975.CrossRefGoogle Scholar
  162. 162.
    Dantchev D, Belpomme D. Critical study of the mononuclear leukocyte morphology based on scanning electron microscopy in normal subjects and in patients with lymphoid or monocytoid proliferative disorders: Comparison with the T. B or null cell membrane phenotypes. Biomedicine 26: 202–222, 1977.PubMedGoogle Scholar
  163. 163.
    Newell DG. Roath S. Smith JL. The scanning electron microscopy of normal human peripheral blood lymphocytes. Br J Haematol 32: 309–316. 1976.PubMedCrossRefGoogle Scholar
  164. 164.
    Polliack A. Normal, transformed, and leukemic leukocytes: A scanning electron microscopy atlas Berlin Springer Verlag, 1977, pp 97–99.Google Scholar
  165. 165.
    Polliack A, Lampcn N, Clarkson BD. et al. Identification of human B and T lymphocytes by scanning electron microscopy. J Exp Med 138: 607–624, 1973.PubMedCrossRefGoogle Scholar
  166. 166.
    Alexander EL, Wetzel B. Human lymphocytes: Similarity of B and T cells surface morphology. Science 188: 7 32–734, 1975.Google Scholar
  167. 167.
    Van Ewijk W, Brons NH, Rozing J. Scanning electron microscopy of homing and recirculating lymphocyte populations. Cell Immunol 19: 245–261, 1975.PubMedCrossRefGoogle Scholar
  168. 168.
    Polliack A. Prokocimer M, Reuven O. et al. Use of multiparameter studies and scanning electron microscopy in the interpretation and attempted correlation of surface morphology with cell type in 135 cases of human leukemias. Cancer Res 41:1171–1179, 1981. Ultrastructural analysis of antibody synthesis in cells from lymph and lymph nodes. Am J Pathol 66: 25–42, 1972.Google Scholar
  169. 169.
    Newell DG, Payne SV, Smith JL, et al. Surface morphology and lymphocyte maturation. In: Becker RP. Johari O, eds. Scanning electron microscopy symposium. AMF O’Hare, III.: SEM, 1978, PP 569–578.Google Scholar
  170. 170.
    Polltack A, Froimovici M, Pozzoli E, et al. Acute lymphoblastic leukemia: A study of 25 cases by scanning electron microscopy. Blut 33: 359–366, 1976.CrossRefGoogle Scholar
  171. 171.
    Loor F. Hägg LB. The modulation of microprojections on the lymphocyte membrane and the redistribution of membrane-bound ligands: A correlation. Eur J Immunol 5: 854–865, 1975.CrossRefGoogle Scholar
  172. 172.
    Avrameas S. Coupling of enzymes to proteins with glutaraldehyde. Immunochemistry 6: 43–52, 1969.PubMedCrossRefGoogle Scholar
  173. 173.
    Kumon H. Morphologically recognizablc markers for scanning immunoelectron microscopy: II. An indirect method using T4 and TMV. Virology 74: 93–103. 1976.PubMedCrossRefGoogle Scholar
  174. 174.
    Lewinski UH. Gafter U, Klein B. et al. Transmission and scanning electron microscopy on Burkitt-like leukemia. Arch Pathol Lab Med 103 558–560. 1979.PubMedGoogle Scholar
  175. 175.
    Polliack A. Normal, transformed, and leukemic leukocytes. A scanning electron microscopy atlas. Berlin: Springer Verlag, 1977. p 125.Google Scholar
  176. 176.
    Gamliel H, Polliack A. Positive identification of human leukemic cells with scanning immunoelectron microscopy, using antibody coated polystyrene (latex) beads as markers. Scand J Haematol 26: 297–305, 1981.PubMedCrossRefGoogle Scholar
  177. 177.
    Gamliel H. Liezerowitz R. Gurfel D, et al. Scanning immunoelectron microscopy of human leukemia and lymphoma cells: A comparative study of techniques, using immunolatex spheres as markers. J Microsc 123: 189–199, 1981.PubMedCrossRefGoogle Scholar
  178. 178.
    Schumacher HR. Stass SA. Creegan WJ, et al. Uropod bearing lymphocytes (hand mirror cells) in a virus-induced murine lymphoma. J Natl Cancer Inst 63: 1051–1055, 1979.PubMedGoogle Scholar
  179. 179.
    Ambros VR, Chen LB, Buchanan JM. Surface ruffles as markers for studies of cell transformation by Rous sarcoma virus. Proc Natl Acad Sci USA 72: 3144–3148, 1975.PubMedCrossRefGoogle Scholar
  180. 180.
    Enlander D. Drew L. Hoo R. et al. The cytopathic effect of Herpes simplex virus on Hep-2 cells as shown by scanning electron microscopy. J Gen Virol 25: 313–316, 1974.PubMedCrossRefGoogle Scholar
  181. 181.
    Hale AH. Winkelhake JL. Weber MJ. Cell surface changes and Rous sarcoma virus give expression in synchronized cells. J Cell Biol 64: 398–407, 1975.PubMedCrossRefGoogle Scholar
  182. 182.
    Holmes KV. Scanning electron microscopic studies of virus infected cells: I. Cytopathic effect and maturation of vesicular stomatitis virus in L2 cells. J Virol 15: 355–362, 1975.PubMedGoogle Scholar
  183. 183.
    Malick LE. Langenbach R. Scanning electron microscopy of in vitro chemically transformed mouse embryo cells. J Cell Biol 68: 654–664, 1976.PubMedCrossRefGoogle Scholar
  184. 184.
    Sjögren U, Garwiez S. Prognostic significance of amoeboid movement configuration in lymphoid cells in children with acute lymphoblastic leukemia. Scand J. Hematol 24: 335–339, 1980.CrossRefGoogle Scholar
  185. 185.
    Haider YS. Phillips TM, Schumacher HR. Acute myeloid leukemia with hand mirror cells. Arch Pathol Lab Med 106: 271–274, 1982.PubMedGoogle Scholar
  186. 186.
    Miller DR. Steinberg PG, Fever D, et al. Prognostic significance of hand mirror cell varient of childhood acute lymphoblastic leukemia. Proc Am Assoc Cancer Res 22: 403, 1981.Google Scholar
  187. 187.
    Alexander E. Henkart P. The adherence of human Fc receptor bearing lymphocytes to antigen-antibody complexes. J Exp Med 143: 329–347, 1976.PubMedCrossRefGoogle Scholar
  188. 188.
    Taylor RB. Duffus PH. Raff MC. et al. Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody. Nature New Biol 233: 225–229, 1971.PubMedCrossRefGoogle Scholar
  189. 189.
    Schumacher HR, Phillips TM. Hand mirror cells in acute lymphoblastic leukemia. Am J Clin Pathol 76: 240–241, 1981.PubMedGoogle Scholar
  190. 190.
    Schumacher HR, Thomas WJ, Strong DM. et al. Acute lymphoblastic leukemia—hand mirror variant: Viral immune interrelationship as demonstrated by ultrastructural studies. Am J Hematol 10:399–403. 1982. leukemias. Cancer Res 41: 1171–1179, 1981.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston/The Hague/Dordrecht/Lancaster 1984

Authors and Affiliations

  • Harold R. Schumacher
  • James D. Cotelingam
  • William K. Hummer

There are no affiliations available

Personalised recommendations